Pothuri B - Search Results

1

Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.

González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. Among authors: pothuri b. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.

2

Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series.

Pothuri B, Vaidya A, Aghajanian C, Venkatraman E, Barakat RR, Chi DS. Pothuri B, et al. Gynecol Oncol. 2003 May;89(2):306-13. doi: 10.1016/s0090-8258(03)00073-8. Gynecol Oncol. 2003. PMID: 12713996

3

The circuitous path of PARP inhibitor development in epithelial ovarian cancer.

Pothuri B. Pothuri B. Oncology (Williston Park). 2012 Feb;26(2):144-6. Oncology (Williston Park). 2012. PMID: 22489347 Free article. No abstract available.

4

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.

Verschraegen CF, Czok S, Muller CY, Boyd L, Lee SJ, Rutledge T, Blank S, Pothuri B, Eberhardt S, Muggia F. Verschraegen CF, et al. Among authors: pothuri b. Ann Oncol. 2012 Dec;23(12):3104-3110. doi: 10.1093/annonc/mds172. Epub 2012 Jul 31. Ann Oncol. 2012. PMID: 22851407 Free article. Clinical Trial.

5

BRCA1- and BRCA2-related mutations: therapeutic implications in ovarian cancer.

Pothuri B. Pothuri B. Ann Oncol. 2013 Nov;24 Suppl 8:viii22-viii27. doi: 10.1093/annonc/mdt307. Ann Oncol. 2013. PMID: 24131965 Free article. Review.

6

Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma.

Graybill WS, Pothuri B, Chase DM, Monk BJ. Graybill WS, et al. Among authors: pothuri b. Gynecol Oncol. 2017 Jul;146(1):11-15. doi: 10.1016/j.ygyno.2017.03.508. Epub 2017 Apr 6. Gynecol Oncol. 2017. PMID: 28392129 No abstract available.

7

Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer.

Lee J, Curtin JP, Muggia FM, Pothuri B, Boyd LR, Blank SV. Lee J, et al. Among authors: pothuri b. Cancer Chemother Pharmacol. 2018 Jul;82(1):55-63. doi: 10.1007/s00280-018-3591-y. Epub 2018 Apr 27. Cancer Chemother Pharmacol. 2018. PMID: 29704010

8

COVID-19 outcomes of patients with gynecologic cancer in New York City.

Lara OD, O'Cearbhaill RE, Smith MJ, Sutter ME, Knisely A, McEachron J, Gabor LR, Jee J, Fehniger JE, Lee YC, Isani SS, Wright JD, Pothuri B. Lara OD, et al. Among authors: pothuri b. Cancer. 2020 Oct 1;126(19):4294-4303. doi: 10.1002/cncr.33084. Epub 2020 Jul 30. Cancer. 2020. PMID: 32729142 Free PMC article.

9

Frontline PARP inhibitor maintenance therapy in ovarian cancer: A Society of Gynecologic Oncology practice statement.

Pothuri B, O'Cearbhaill R, Eskander R, Armstrong D. Pothuri B, et al. Gynecol Oncol. 2020 Oct;159(1):8-12. doi: 10.1016/j.ygyno.2020.07.097. Epub 2020 Aug 7. Gynecol Oncol. 2020. PMID: 32778410

10

PARP inhibition as frontline therapy in ovarian cancer.

Moore KN, Pothuri B, Monk B, Coleman RL. Moore KN, et al. Among authors: pothuri b. Clin Adv Hematol Oncol. 2020 Sep;18(9):550-556. Clin Adv Hematol Oncol. 2020. PMID: 33006584 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page